Supresion nocturna con alta dosis de dexametasona y test de metopirona en el diagnostico etiologico del sindrome de cushing

Medicina

Volumn 56, Issue 5 I, 1996, Pages 455-462

  Rossi, Maria A ^a   Chervin, Raul A ^a   Bruno, Oscar D ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DIAGNOSTIC AGENT; METYRAPONE; HYDROCORTISONE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; COMPARATIVE STUDY; CUSHING SYNDROME; FEMALE; HUMAN; MALE; MIDDLE AGED; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY;

ADOLESCENT; ADULT; CUSHING SYNDROME; DEXAMETHASONE; FEMALE; HUMANS; MALE; METYRAPONE; MIDDLE AGED;

EID: 0030451798     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kaye TB, Crapo L. The Cushing's syndrome: An update on diagnostic tests. Ann Intern Med 1990; 112: 434-44.
2. Becker M, Aron DC. Ectopic ACTH syndrome and CRH-mediated Cushing's syndrome. Endocrinol Metab Clin NA 1994; 23: 585-606.
3. Leinung MC, Young WF Jr, Whitaker MD, Scheithauer BW, Trastek VF, Kvols LK. Diagnosis of corticotropin-producing bronchial carcinoid tumors causing Cushing's syndrome: Mayo Clin Proc 1990; 65: 1314-21.
4. De Stephano DB, Lloyd RB, Schteingart DE. Cushing's syndrome produced by a bronchial carcinoid tumor. Human Pathol 1984; 15: 890-2.
5. Doppman JL, Frank JA, Dwyer AJ, et al. Gadolinium DTPA enhanced MR imaging of ACTH-secreting microadenomas of the pituitary. J. Comput Assist Tomogr 1988; 12: 728-35.
6. Nugent CA, Nichols T, Tyler FH. Diagnosis of Cushing's syndrome. Single dose dexamethasone suppression test. Arch Intern Med 1965; 116: 172-6.
7. Contreras LN, Hane S, Tyrrell B. Urinary cortisol in the assessment of pituitary-adrenal function: Utility of 24-hour and spot determination. J Clin Endocrinol Metab 1986; 62: 965-9.
8. Contreras LN, Masini AM, Rossi MA, Bruno OD. Spot urinary cortisol in assessing circadian variability in patients with Cushing's syndrome (CS), obesity, hyper and hypothyroidism. Journèes Internationales Henri-Pierre Klotz d'Endocrinologie Clinique, Paris, 1988.
9. Porter CC, Silber RH. A quantitative color reaction for cortisone and related 17, 21-dihydroxyketosteroids. J Biol Chem 1950; 185: 201-7.
10. Sackett DL, Haynes RB, Tugwell P. The interpretation of diagnostic data. In: Clinical Epidemiology. Boston: Little, Brown 1985, p 59.
11. Sparks LL, Smilo RP, Palatos FC, Forsham PH. Experience with a rapid oral metyrapone test and the plasma ACTH content in determining the cause of Cushing's syndrome. Metabolism 1969; 18: 175-92.
12. Findling JW. Clinical aplication of a new immunoradiometric assay for ACTH. The Endocrinologist 1992; 2: 360-5.
13. Howlett TA, Drury LP, Perry DL, Doniach I, Rees LH, Besser GM. Diagnosis and management of ACTH-dependent Cushing's syndrome: Comparation of the features in ectopic and pituitary ACTH production. Clin Endocrinol 1986; 24: 699-713.
14. Liddle GW. Test of pituitary-adrenal suppressibility in the diagnosis of Cushing's symdrome. J Clin Endocrinol Metab 1960; 20: 1539-61.
15. Aron DC, Findling JW, Tyrrell JB, Fitzgerald PA, Forsham PH. The overnight high-dose dexamethasone suppression test: a rapid method of differential diagnosis in Cushing's syndrome Horm Res 1980; 13: 334.
16. Bruno OD, Rossi MA, Contreras LN, et al. Nocturnal high-dose dexamethasone suppression test in the aetiological diagnosis of Cushing's syndrome. Acta Endocrinol 1985; 109: 158-62.
17. Tyrrell JB, Findling JW, Aron DC, Fitzgerald PA, Forsham PH. An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing's syndrome. Ann Intern Med 1986; 104: 180-6.
18. Dichek HL, Nieman LK. Oldfield EH, Pass HI, Malley JD, Cutler GB. A comparison of the standard high dose dexamethasone suppression test and the overnight 8 mg dexamethasone suppression test for the diferential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 1994; 78: 418-22.
19. Jubiz W, Wayne Meikle A, West CD, Tyler FH. Single-dose metyrapone test. Arch Intern Med 1970; 125: 472-4.
20. Spiger M, Jubiz W, Wayne Meikle A, West CD, Taylor FH. Single-dose metyrapone test. Arch Intern Med 1975; 135: 698-700.
21. Bruno OD, Rossi MA, Contreras LN. Diagnosis of Cushing's disease (letter to the editor). Ann Intern Med 1990; 113: 807.
22. Carpenter PC. Diagnostic evaluation of Cushing's syndrome. Endocrinol Metab Clin NA 1988; 17: 445-72.
23. Schteingart DE. Cushing's syndrome. Endocrinol Metab Clin NA 1989; 18: 311-38.
24. Sindler BH, Griffing GT, Melby JC. The superiority of the metyrapone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing's syndrome. Am J Med 1983; 74: 657-62.
25. Bruno OD, Estivariz F, Contreras LN, De Nicola A, Rossi MA. Regulación de la secreción de cortisol en el síndrome de ACTH-ectópico por carcinoide bronquial. Medicina (Buenos Aires) 1987; 47: 609.
26. Findling JW, Doppman JL. Biochemical and radiologic diagnosis of Cushing's syndrome. Endocrinol Metab Clin NA 1994; 23: 511-37.
27. Miller DL, Doppman JL, Peterman SB, et al. Neurologic complications of petrosal sinus sampling. Radiology 1992; 185: 143-7.